-
Orforglipron (LY-3502970) is an oral, non-peptide,
small molecule glucagon-like peptide-1
receptor agonist developed as a
weight loss drug by Eli Lilly...
-
reported adverse events were nausea, diarrhea, and vomiting.
Lotiglipron Orforglipron Griffith DA,
Edmonds DJ,
Fortin JP,
Kalgutkar AS,
Kuzmiski JB, Loria...
-
enzymes which could indicate potential for
liver toxicity.
Danuglipron Orforglipron US 10676465,
Aspnes GE, et al., "GLP-1
receptor agonists and uses thereof"...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
- Albiglutide‡ Danuglipron†
Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§
Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins"
Alogliptin Anagliptin...
